Price target
19.380.000.00%
The 5 analysts offering 1 year price forecasts for FRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to FRX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
FRX EPS for the last quarter is −0.28 CAD despite the estimation of −0.12 CAD. In the next quarter EPS is expected to reach −0.19 CAD. Track more of FENNEC PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter FENNEC PHARMACEUTICALS INC revenue is expected to reach 11.62 M CAD. Check out FENNEC PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, FRX price target is 19.38 CAD with a max estimate of 21.38 CAD and a min estimate of 17.10 CAD. Check if this forecast comes true in a year, meanwhile watch FENNEC PHARMACEUTICALS INC stock price chart and keep track of the current situation with FRX news and stock market news.
We've gathered opinions of 5 analysts rating FRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.